Analogues of p38 MAP kinase inhibitor RPR-200765A with improved profile obtained at Aventis April 6, 2001
New matrix metalloproteinase inhibitors and potential uses claimed by former Warner-Lambert April 4, 2001
Chemokine receptor antagonists designed as part of joint Millennium/Kyowa Hakko program March 28, 2001